SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

BRIEF-Amphastar Announces Buyback Of 26% Of The Equity In Its Anp Subsidiary And Spin-Off Its Hanxin Subsidiary

05/07/2021 16:09
BRIEF-Amphastar Announces Buyback Of 26% Of The Equity In Its Anp Subsidiary And Spin-Off Its Hanxin Subsidiary

- Amphastar Pharmaceuticals Inc AMPH.O:

  • AMPHASTAR ANNOUNCES BUYBACK OF 26% OF THE EQUITY IN ITS ANP SUBSIDIARY AND SPIN-OFF ITS HANXIN SUBSIDIARY

  • AMPHASTAR PHARMACEUTICALS INC - ANNOUNCED RESTRUCTURING OF ITS CHINESE SUBSIDIARIES, PRIMARILY AMPHASTAR NANJING PHARMACEUTICALS INC

  • AMPHASTAR PHARMACEUTICALS INC - TOTAL CASH PAYMENT BY AMPHASTAR FOR THIS RESTRUCTURING WILL BE APPROXIMATELY $29 MILLION

  • AMPHASTAR PHARMACEUTICALS - EXPECT TRANSACTION TO BE ACCRETIVE TO AMPHASTAR'S EPS BY APPROXIMATELY $0.03 PER SHARE IN 2021 AND $0.12 PER SHARE IN 2022

  • AMPHASTAR PHARMA- SOME OF ANP INVESTORS WILL CONCURRENTLY INVEST A PORTION OF THEIR ANP SALE PROCEEDS TO PURCHASE A MAJORITY OWNERSHIP STAKE IN HANXIN

Source text for Eikon: ID:nGNX3kstmc

Further company coverage: AMPH.O


(([email protected];))